Live Breaking News & Updates on Athelon Medical

Stay updated with breaking news from Athelon medical. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4.7 Million Public Offering

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Pricing of $4.7 Million Public Offering
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

New York , United States , Susan Noonan , Jim Frakes , Maxim Group , Athelon Medical Inc , Drug Administration , Securities Exchange , Exchange Commission , Newswire Aethlon Medical Inc , Sa Noonan Communications , Company Annual Report On Form , Company Contact , Prospectus Department , Aethlon Medical Inc , Aethlon Medical , Breakthrough Device , Investigational Device Exemption , Securities Act , Securities Exchange Act , Annual Report , Chief Executive Officer , Chief Financial , Athelon Medical ,

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
investorideas.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from investorideas.com Daily Mail and Mail on Sunday newspapers.

James Frakes , Jim Frakes , Susan Noonan , Cellarcus Biosciences Inc , Athelon Medical Inc , Securities Exchange , Sa Noonan Communications , Exchange Commission , Aethlon Medical Inc , Newswire Aethlon Medical Inc , Drug Administration , Company Annual Report On Form , Company Contact , Aethlon Medical , Interim Chief Executive Officer , Chief Financial Officer , Cellarcus Biosciences , Clinical Investigator Brochure , Ethics Committees , Breakthrough Device , Investigational Device Exemption , Securities Act , Securities Exchange Act , Annual Report , Chief Executive Officer , Chief Financial ,

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Enters Into Materials Transfer Agreement for Santersus AG s NucleoCapture and HemoNucleoCapture Devices ....

City Of , United Kingdom , James Frakes , Santersu Nucleocapture , Scott Maguire , Jim Frakes , Aethlon Hemopurifier , Susan Noonan , Us Food Drug Administration , Company Annual Report On Form , Aethlon Medical Inc , Athelon Medical Inc , Drug Administration , Company Contact , Exchange Commission , Sa Noonan Communications , Securities Exchange , Newswire Aethlon Medical Inc , Aethlon Medical , Materials Transfer Agreement , Neutrophil Extracellular Traps , Interim Chief Executive Officer , Chief Financial Officer , Breakthrough Device , Investigational Device Exemption , Securities Act ,

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Fiscal Third Quarter Financial Results and Provides Corporate Update

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) Announces Fiscal Third Quarter Financial Results and Provides Corporate Update ....

Jim Frakes , James Frakes , Susan Noonan , Maulana Azad Medical College , Athelon Medical Inc , Participant International Dial , Company Annual Report On Form , Company Contact , Sa Noonan Communications , Exchange Commission , Drug Administration , Aethlon Medical Inc , Newswire Aethlon Medical Inc , Securities Exchange , Company Updates , Aethlon Medical , Drug Controller General , Ethics Boards , Interim Chief Executive Officer , Chief Financial , Medanta Medicity Hospital , Chief Executive Officer , Third Quarter Ended December , Toll Free , Breakthrough Device , Investigational Device Exemption ,

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024

Breaking Medical Technology News: Aethlon Medical (NASDAQ: AEMD) to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024 ....

Susan Noonan , Jim Frakes , Company Annual Report On Form , Securities Exchange , Sa Noonan Communications , Exchange Commission , Aethlon Medical Inc , Newswire Aethlon Medical Inc , Company Contact , Athelon Medical Inc , Drug Administration , Aethlon Medical , Breakthrough Device , Investigational Device Exemption , Securities Act , Securities Exchange Act , Annual Report , Athelon Medical , Aethlon Medical , Fiscal Third Quarter , Financial Results , Conference Call , February 14 ,